Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Tata India Pharma & Healthcare Fund-Regular Plan-Growth - Portfolio Analysis

Portfolio Overview

As of December 31, 2025

Icon Portfolio

Asset Allocation

Equity: 98.69%Others: 1.31%
Icon Portfolio

Market Cap

Large Cap: 19.91%Mid Cap: 40.02%Small Cap: 37.23%Equity: 1.52%
Icon Portfolio

Number of stocks

37
Icon Portfolio

Top 10 Holdings

98.02% of portfolio

Market Cap of Equity

Large Cap
19.9150%
Mid Cap
40.0169%
Small Cap
37.2311%
Equity
1.5219%

Companies Allocation of Equity

Sun Pharmaceuticals Industries Ltd15.77%
Max Healthcare Institute Ltd Ordinary Shares11.75%
Abbott India Ltd10.97%
Divi's Laboratories Ltd10.02%
HealthCare Global Enterprises Ltd9.68%
Apollo Hospitals Enterprise Ltd9.51%
Cipla Ltd8.29%
Rainbow Childrens Medicare Ltd7.54%
Ipca Laboratories Ltd7.45%
J.B. Chemicals & Pharmaceuticals Ltd7.05%

Sector Allocation of Equity

Healthcare95.00%
Basic Materials3.68%

SIP Amount

Monthly SIP Date

Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.